搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Synechococcus sp. Glycine/sarcosine N-methyltransferase (bsmA) CSB-YP756102SSL
CSB-EP756102SSL
CSB-BP756102SSL
CSB-MP756102SSL
CSB-EP756102SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. NAD (P)H-quinone oxidoreductase subunit 2 (ndhB), partial CSB-YP756103SSL
CSB-EP756103SSL
CSB-BP756103SSL
CSB-MP756103SSL
CSB-EP756103SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP756104SSL
CSB-EP756104SSL
CSB-BP756104SSL
CSB-MP756104SSL
CSB-EP756104SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Adenylosuccinate synthetase (purA) CSB-YP756105SSL
CSB-EP756105SSL
CSB-BP756105SSL
CSB-MP756105SSL
CSB-EP756105SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem I reaction center subunit XII (psaM), partial CSB-YP756106SSL
CSB-EP756106SSL
CSB-BP756106SSL
CSB-MP756106SSL
CSB-EP756106SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Putative membrane protein insertion efficiency factor (SYNW1693) CSB-YP756107SSL
CSB-EP756107SSL
CSB-BP756107SSL
CSB-MP756107SSL
CSB-EP756107SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. ATP-dependent Clp protease proteolytic subunit 3 (clpP3) CSB-YP756108SSL
CSB-EP756108SSL
CSB-BP756108SSL
CSB-MP756108SSL
CSB-EP756108SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable inorganic polyphosphate/ATP-NAD kinase 1 (ppnK1) CSB-YP756109SSL
CSB-EP756109SSL
CSB-BP756109SSL
CSB-MP756109SSL
CSB-EP756109SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Histidine biosynthesis bifunctional protein HisIE (hisI) CSB-YP756110SSL
CSB-EP756110SSL
CSB-BP756110SSL
CSB-MP756110SSL
CSB-EP756110SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 30S ribosomal protein S21 (rpsU) CSB-YP756111SSL
CSB-EP756111SSL
CSB-BP756111SSL
CSB-MP756111SSL
CSB-EP756111SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem I reaction center subunit PsaK (psaK), partial CSB-YP756112SSL1
CSB-EP756112SSL1
CSB-BP756112SSL1
CSB-MP756112SSL1
CSB-EP756112SSL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Phosphopantetheine adenylyltransferase (coaD) CSB-YP756113SSL
CSB-EP756113SSL
CSB-BP756113SSL
CSB-MP756113SSL
CSB-EP756113SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. UPF0182 protein SYNW1212 (SYNW1212), partial CSB-YP756114SSL
CSB-EP756114SSL
CSB-BP756114SSL
CSB-MP756114SSL
CSB-EP756114SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Cytochrome c biogenesis protein CcsA (ccsA), partial CSB-YP756115SSL
CSB-EP756115SSL
CSB-BP756115SSL
CSB-MP756115SSL
CSB-EP756115SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Glutamyl-tRNA (Gln) amidotransferase subunit A (gatA) CSB-YP756116SSL
CSB-EP756116SSL
CSB-BP756116SSL
CSB-MP756116SSL
CSB-EP756116SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP756117SSL
CSB-EP756117SSL
CSB-BP756117SSL
CSB-MP756117SSL
CSB-EP756117SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP756118SSL
CSB-EP756118SSL
CSB-BP756118SSL
CSB-MP756118SSL
CSB-EP756118SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase (hisA) CSB-YP756119SSL
CSB-EP756119SSL
CSB-BP756119SSL
CSB-MP756119SSL
CSB-EP756119SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 2-isopropylmalate synthase (leuA), partial CSB-YP756120SSL
CSB-EP756120SSL
CSB-BP756120SSL
CSB-MP756120SSL
CSB-EP756120SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP756121SSL
CSB-EP756121SSL
CSB-BP756121SSL
CSB-MP756121SSL
CSB-EP756121SSL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>